Adapta&on and Design of Panels for the CyTOF. December 5, 2014 CyTOF User Mee&ng University of Virginia Mike Leipold

Similar documents
Ge#ng started on the CyTOF: learning by living. Alice Long and BRI HIP core team 2013

Categorical analysis of human T cell heterogeneity with One-SENSE

BD Flow Cytometry Reagents Multicolor Panels Designed for Optimal Resolution with the BD LSRFortessa X-20 Cell Analyzer

A step-by-step approach to build and analyze a multicolor panel

Next-Generation Immunohistochemistry: Multiplex tissue imaging with mass cytometry

ab Exosome Isolation and Analysis Kit - Flow Cytometry, Plasma

ANALYTISCHE STRATEGIE Tissue Imaging. Bernd Bodenmiller Institute of Molecular Life Sciences University of Zurich

Supplementary Fig. 1: Ex vivo tetramer enrichment with anti-c-myc beads

Do Your Flow Cytometric LDTs. Validation Guidelines? Fiona E. Craig, MD University of Pittsburgh School of Medicine

Supplementary Materials Extracting a Cellular Hierarchy from High-dimensional Cytometry Data with SPADE

Mass Cytometry Publication List

ab Exosome Isolation and Analysis Kit - Flow Cytometry, Cell Culture (CD63 / CD81)

DuraClone IM. Standardized phenotyping panels for studies of the human immune system

Concentration Estimation from Flow Cytometry Exosome Data Protocol

Application Information Bulletin: Human NK Cells Phenotypic characterizing of human Natural Killer (NK) cell populations in peripheral blood

ab Exosome Isolation and Analysis Kit - Flow Cytometry, Cell culture

DURACLONE IF BE CERTAIN ABOUT THE RESPONSE. l res. a il n c n. For Research Use Only - Not for use in Diagnostic procedures

x Lymphocyte count /µl CD8+ count/µl 800 Calculated

VUmc Basispresentatie

Detection. personal. Now, you can optimize your personal workflow. Promega instruments and reagents integrate easily.

Titrations in Cytobank

Optimizing Intracellular Flow Cytometry:

HD1 (FLU) HD2 (EBV) HD2 (FLU)

Fluorochrome Panel 1 Panel 2 Panel 3 Panel 4 Panel 5 CTLA-4 CTLA-4 CD15 CD3 FITC. Bio) PD-1 (MIH4, BD) ICOS (C398.4A, Biolegend) PD-L1 (MIH1, BD)

Measuring Dendritic Cells

Nature Immunology: doi: /ni Supplementary Figure 1. Examples of staining for each antibody used for the mass cytometry analysis.

MHC MULTIMER PROFICIENCY PANEL 2017

DURACLONE RE THERE ARE EVENTS YOU CANNOT AFFORD TO MISS

Comprehensive evaluation of human immune system reconstitution in NSG. and NSG -SGM3 mouse models toward the development of a novel ONCO-HU

Optimizing Intracellular Flow Cytometry:

Supplementary Data. Treg phenotype

Detailed step-by-step operating procedures for NK cell and CTL degranulation assays

BD CBA on the BD Accuri C6: Bringing Multiplexed Cytokine Detection to the Benchtop

ISCT Workshop #7 Perspectives in Cell Selection Immunomagnetic Selection

Cover Page. The handle holds various files of this Leiden University dissertation.

Gladstone Institutes, University of California (UCSF), San Francisco, USA

Peptide stimulation and Intracellular Cytokine Staining

MATERIALS. Peptide stimulation and Intracellular Cytokine Staining- EFFECTOR 45RA PANEL

Automating Mass Spectrometry-Based Quantitative Glycomics using Tandem Mass Tag (TMT) Reagents with SimGlycan

CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets!

Systems Biology Approaches to Influenza Vaccination

Analy?cal strategy. Tissue imaging. Prof. Detlef Günther Prof. Renato Zenobi. Sahar Ghiasikhou Kaspar Andreas Kuster Beatrice

Pearson r = P (one-tailed) = n = 9

BD FACSCanto. BD FACSCanto. 488nm 20mw 633nm 17mw 0.1% 120uL/min 10,000events/sec. BD Biosciences 1

DEVELOPMENTAL VALIDATION OF SPERM HY-LITER EXPRESS Jennifer Old, Chris Martersteck, Anna Kalinina, Independent Forensics, Lombard IL

Performance Characteristics of the Agilent High Matrix Sample Introduction (HMI) Accessory for the 7500 Series ICP-MS. Product Overview.

In vitro human regulatory T cell expansion

Supplementary Table 1: Summary of Reactogenicity Events by Group and Time of Onset in Entebbe

Supporting Information

Superior Fluorescent Labeling Dyes Spanning the Full Visible Spectrum...1. Trademarks: HiLyte Fluor (AnaSpec, Inc.)

In vitro human regulatory T cell expansion

In vitro human regulatory T cell suppression assay

Assigning B cell Maturity in Pediatric Leukemia Gabi Fragiadakis 1, Jamie Irvine 2 1 Microbiology and Immunology, 2 Computer Science

Activity # 4. Measurement of Enzyme Activity

Blocking antibodies and peptides. Rat anti-mouse PD-1 (29F.1A12, rat IgG2a, k), PD-

Nature Protocols: doi: /nprot Supplementary Figure 1

Primary Adult Naïve CD4+ CD45RA+ Cells. Prepared by: David Randolph at University of Alabama, Birmingham

Supplemental Figure 1. IL-3 blockade with Fab CSL362 depletes plasmacytoid dendritic cells (pdcs), but not basophils, at higher doses.

Use of standardized lyophilized reagents to develop a functional T- cell signature. John F. Dunne, PhD Assoc. Scientific Director BD Biosciences

Mass Cytometry Applications for Immunology Research. Pub Note PN 13 01_150505

a Beckman Coulter Life Sciences: White Paper

BD OneFlow LST Application Guide

Determination of Copper in Green Olives using ICP-OES

Using CART to Mine SELDI ProteinChip Data for Biomarkers and Disease Stratification

B and T-Cells. CD8+ Cytotoxic T Cells

For Research Use Only

Supplementary Data 1. Alanine substitutions and position variants of APNCYGNIPL. Applied in

New technologies for studying human immunity. Lisa Wagar Postdoctoral fellow, Mark Davis lab Stanford University School of Medicine

Analysis of Micronutrients in Milk by Flame Atomic Absorption Using FAST Flame Sample Automation for Increased Sample Throughput

Transcript-indexed ATAC-seq for immune profiling

Optimizing Intracellular Flow Cytometry

Lab 1 - Klinisk Kemisk Diagnos9k

DIFFERENCES IN T-CELL SUBSETS IN ME/CFS. University of Nevada, Reno. Determining the Difference Between Circulating Follicular Regulatory T-cells and

Supplementalgfigureg1gSchematicgdiagramgofgtumor1modellingg

Measuring Lipid Composition LC-MS/MS

of human hair and nails. Part I. Analytical methodology, Sci. Tot. Environ. 2000, 250/1-3,

Automated Purification and Analytical Reinjection of a Small Molecule Drug, Probenecid, on a Gilson LC/MS Dual Function System

EpiQuik Circulating Acetyl Histone H3K18 ELISA Kit (Colorimetric)

How to set up a good protocol or Polychromatic flow cytometry: Advantages and pitfalls

ab HIV-1 Protease Inhibitor Screening Kit (Fluorometric)

For research or further manufacturing use only. Not for injection or diagnostic procedures.

Figure S1. Generation of inducible PTEN deficient mice and the BMMCs (A) B6.129 Pten loxp/loxp mice were mated with B6.

Phospholipid characterization by a TQ-MS data based identification scheme

Commercially available HLA Class II tetramers (Beckman Coulter) conjugated to

Application of μmacs Streptavidin MicroBeads for the analysis of HIV-1 directly from patient plasma

Supplementary Figure 1

STANDARD SAMPLE INTRODUCTION

Complete Transcriptome Analysis of Latently Infected CD4 + T Cells

<10. IL-1β IL-6 TNF + _ TGF-β + IL-23

LDL Uptake Flow Cytometry Assay Kit

Human TSH ELISA Kit. User Manual

Tools for MRD in AML: flow cytometry

Comparison of Simultaneous Nitrofuran (NF) and Chloramphenicol (CAP) Analytical Methods for AOAC Validation Study

Immune Cell Phenotyping in Solid Tumors using Quantitative Pathology

Understanding Poor Vaccine Responses: Transcriptomics of Vaccine Failure

Nature Medicine: doi: /nm.2109

Establishing a Pure Lymphocyte Gate for Subset Analysis by Flow Cytometry

MagCapture Exosome Isolation Kit PS Q&A

Transcription:

Adapta&on and Design of Panels for the CyTOF December 5, 214 CyTOF User Mee&ng University of Virginia Mike Leipold

Two Different Approaches to Simultaneous Detec&on Fluorophores Elemental Tagging Fluorometer Induc&vely Coupled Plasma Mass Spectrometry (ICP- MS)

Two Different Approaches to Simultaneous Detec&on 8 Alexa Fluorophores Elemental Tagging 1 9 8 7 intensity 6 5 4 3 2 1 38 43 426 449 472 495 518 541 564 587 61 633 wavelength 656 679 72 725 748 771 794 LSR II CyTOF

Overview 1. CyTOF the machine, pros and cons 2. Panel development background, desired signals 3. Experimental procedures an&bodies, reagents 4. Running samples example data - LSRII vs CyTOF - Flu 21, 211

Part 1 The CyTOF

Single Cell Analysis - CyTOF TM Machine Flow Interface to ICP- MS - Nebulizer vaporizes Flow - Argon Plasma atomizes and ionizes - Mass analyzer Figure courtesy O. Ornatsky

Single Cell Analysis - CyTOFTM Machine Published in: Dmitry R. Bandura; Vladimir I. Baranov; Olga I. Ornatsky; Alexei Antonov; Robert Kinach; Xudong Lou; Serguei Pavlov; Sergey Vorobiev; John E. Dick; Scob D. Tanner; Anal. Chem. 29, 81, 6813-6822. DOI: 1.121/ac9149w Copyright 29 American Chemical Society

Display of Cell Events Monocyte? CD8+ T cell? B cell? - Push analogous to &me: 76,8 pushes/sec: 22 displayed here (1/4 of data)

Pros of CyTOF - Advantages: - Minimal "spectral" overlap higher dimensionality (more probes at once) - Quan&ta&ve broad dynamic range - Not light- or &me- sensi&ve - Minimal background - no analogy to autofluorescence: low/nil biological background for lanthanides

Cons of CyTOF - Disadvantages: - Destruc&ve: (currently) no way to recover interes&ng cells - Slower: limit of 1 cells/sec; prac&cal limit for best resolu&on oken in ~4 cells/sec range - Cell transmission efficiency: only ~2-3% of cells that enter machine get counted - Ion transmission efficiency: only ~1 in 1, ions that enter machine get counted

Cons of CyTOF - Disadvantages: - Postprocessing: cannot set on fly gates to get only live intact singlets - Events registered by CyTOF contains debris, doublets, etc - Might only get ~5% of total events as live intact singlets - No analogy to FSC or SSC: MUST have marker (M n+ ) for any ga&ng

Single Cell Analysis - CyTOF TM Machine - CyTOFv1 ~21- May 213 - Mass window ~93 units: eg, AW 13-195 - CyTOFv2 May 213- current - Mass window ~135 units: eg, AW 78-212 - More automated tuning, including recordkeeping - Improvements in ion op&cs - &ghter peaks, less "spillover"

Part 2 Panel Design

Relevant Issues to Panel Design 1. Background any non- desired signal - contamina&ng signals - an&body &ter (not discussed) 2. Desired Signal - an&body clone - metal label analogous to fluorophore choice

Relevant Issues to Panel Design Background Signals * Desired signal only at Mass "M" 1. M+16 oxide cannot eliminate, can only limit 2. Metal salt impuri&es M+1, M- 1, etc; Ln 3. Environmental contamina&on sample 4. Instrument * All poten&al sources of background, even spillover!

Relevant Issues to Panel Design Background Signals * Desired signal only at Mass "M" 1. M+16 oxide cannot eliminate, can only limit - Proper daily machine tuning - Lower AW Ln = worse

Daily Tuning Liquid Tuning Solu&on Current profile Make- up Gas profile

DVS Elemental Beads "Cells" - Polystyrene beads: contain nat. abund. Eu; or La, Pr, Tb, Tm, Lu - Act as "cells" run in acquisi&on mode (vs. tuning/solu&on mode) 1 4 (La139)Dd: (La139)Dd 1 3 1 2 1 1 Makeup Gas Flow Rates - Median Dual counts vs AW 2 MG =.74 15 1 1 1 2 1 3 1 4 (Pr141)Dd: (Pr141)Dd Median Dual Count 1 (Tb159)Dd: (Tb159)Dd 1 4 1 3 1 2 1 1 5 14 15 16 17 18 Atomic Mass 1 1 1 2 1 3 1 4 (Tm169)Dd: (Tm169)Dd

Effect of Tuning Beads - Oxida&on Linear Scale Median Dual counts Log Scale Median Dual counts Median Dual Count 2 15 1 La139 Pr141 Tb159 Tm169 Lu175 "Gd155" "Gd157" "Re185" Median Dual Count 1 1 1 1 1 La139 Pr141 Tb159 Tm169 Lu175 "Gd155" "Gd157" "Re185" 5.1.5.6.7.8.9 1. * Makeup Gas Flow Rate (L/min).1.5.6.7.8.9 1. * Makeup Gas Flow Rate (L/min) - At high MG flow rate, oxida&on can be significant (decreases M, increases M+16 spillover) - Even a few percent can be significant for high- abundance markers (eg, CD57, histone proteins, CD45, etc)

Relevant Issues to Panel Design Background Signals * Desired signal only at Mass "M" 2. Metal salt impuri&es a) Few lanthanides are naturally 1% monoisotopic - e.g., Nd144 signal in Nd145 salt - M+1, M- 1, etc b) Other lanthanide contamina&ons all Ln chemistry is similar - La139 most common contaminant

Purity of Isotopes Liquid Stock Solu&ons CyTOF Channel Single- Isotope Sample - - M+1 impuri&es some isotopes worse than others M+16 oxida&on impuri&es affects all isotopes; lower AW worst

BD Ig Κ Capture Beads and MAXPAR An&bodies M- 1 146 M M+1 Sm147 148 4 15 5 # Cells 3 2 1 # Cells 1 5 # Cells 4 3 2 1 1 1 1 2 1 3 1 4 IgD(Nd146)Dd: IgD 1 1 1 2 1 3 1 4 CD85j(Sm147)Dd: CD85j 1 1 1 2 1 3 1 4 Nd148(Nd148)Dd: Nd148 No "Sm146" - 146 is Nd * Spillover due to elemental and/or isotopic impuri&es, not strictly mass proximity

Major Contaminants/Spillovers: Percentage of M - M+1 and M+16 are usually the major spillovers - Only Fluidigm metals shown; non- Fluidigm metals can be worse * Ir191 contam?

Major Contaminants/Spillovers: Cell Data * Formerly, Fluidigm sold Dy162 and Dy164, but not Dy163 Dy purity issues Regular Phenotyping panel: CD45RA- Dy162 CD2- Dy164 * no Dy163 an&body in experiment, so not usually monitored

Major Contaminants/Spillovers: Cell Data CD45RA- Dy162 CD2- Dy164 * no Dy163 an&body in experiment! Magenta: both Dy162, Dy164 Blue: Dy162 only Red: Dy164 only 1 CD3+ 1 B cells % of Max 8 6 4 - no CD2 % of Max 8 6 4 - high CD2, high CD45RA 2 2 1 1 1 2 1 3 1 4 (Dy163)Dd 1 1 1 2 1 3 1 4 (Dy163)Dd

Relevant Issues to Panel Design Background Signals 3. Environmental contamina&on - Reagents PFA lots with micropar&cles, MeOH with free metal, Ar gas with Sn - Biological sourcing Iodine (free I vs IdU), Pt in cispla&n- treated donor samples - Lab dust - Barium, lead, etc dish soap, syringes, reagent sourcing, striker flint, etc

Relevant Issues to Panel Design Background Signals 4. Instrument Abundance Sensi&vity lek (M- 1) and right (M+1) leg of ion peak - CyTOFv1: - 1% - CyTOFv2: <.3% 4 # Cells 3 2 1 - Worse with high AW masses: peak less Gaussian, M+1 leg wider 1 1 1 2 1 3 1 4 (Sm147)Dd: CD85j

Major Contaminants/Spillovers: Percentage of M * CyTOF spillover - s&ll much less than Fluorescence spillover! * All propor&onal to signal at Mass "M"... 1. Match marker abundance with metal brightness - 1% of 3 is 3 (background) - 1% of 3 is 3 (probably not background) 2. Mutually exclusive lineages - T cell marker followed by B cell marker 3. Dump channels for most contaminated isotopes - analyze the "nega&ve" cells

Desired Signal Intensity- Choice of Metal Reminder: you cannot detect anything that doesn't have bound metal - No scaber to gate monocytes from lymphocytes, etc - Only about 3- fold difference in signal across lanthanides - Switching lanthanides might help only in borderline cases

Desired Signal Intensity- Choice of Metal 1 4 Lower sensitivity (139-15) # Cells 15 1 5 CD56(Yb174)Dd: CD56 1 3 1 2 1 1 1 1 1 2 1 3 1 4 CD3(Nd15)Dd: CD3 1 1 1 2 1 3 1 4 CD16(Sm149)Dd: CD16 2 1 4 Higher sensitivity (165-17) # Cells 15 1 5 CD56(Yb174)Dd 1 3 1 2 1 1 1 1 1 2 1 3 1 4 CD3(Tm169)Dd 1 1 1 2 1 3 1 4 CD16(Ho165)Dd

Desired Signal Intensity- Choice of Metal 1. "Dim" metals In, La, Pr, Nd, Sm - Bright/abundant markers (eg, CD57) - True bimodal (eg, CD27) 3 CD8+ 8 CD4+ 6 # Cells 2 # Cells 4 1 2 1 1 1 2 1 3 1 4 (In113)Dd: CD57 1 1 1 2 1 3 1 4 CD27(Sm152)Dd: CD27

Desired Signal Intensity- Choice of Metal 2. "Bright" metals Tb, Dy, Tm, Yb - Dim/rare markers - "Smear" distribu&on (eg, CD45RA, CCR7) - Small fold- change 1 3 1 2 1 1 TCRgd(Yb171)Dd: TCRgd14 TCRgd 3.29 # Cells 2 15 1 5 CD8+ 1 1 1 2 1 3 1 4 CD3(Nd15)Dd: CD3 1 1 1 2 1 3 1 4 CD45RA(Dy162)Dd: CD45RA

Desired Signal Intensity- Choice of Metal 3. Recommend bivariates - one bright, one dim - two mediums "smear", or subpopula&ons CD2(Dy164)Dd: CD2 1 4 1 3 1 2 1 1 B cells 48.2 (Er166)Dd: CD33 1 4 1 3 1 2 1 1 CD14- CD33-84.8 CD14+ CD33+ 14.9 1 1 1 2 1 3 1 4 CD19(Nd142)Dd: CD19 1 1 1 2 1 3 1 4 (Sm154)Dd: CD14

Desired Signals CD85j as a Borderline Case CD4+ CD8+ Monocytes 2 2 3 15 15 # Cells 2 1 CD85j- 96.9 CD85j+ 3.7 # Cells 1 5 CD85j- 82.1 CD85j+ 17.9 # Cells 1 5 CD85j- 3.85 CD85j+ 96.2 1 1 1 2 1 3 1 4 (Sm147)Dd: CD85j 1 1 1 2 1 3 1 4 (Sm147)Dd: CD85j 1 1 1 2 1 3 1 4 (Sm147)Dd: CD85j "nega&ve" subpopula&on "posi&ve"

Confirm New Markers With More Than One Donor TCRgd (Yb171)Dd: TCRgd 1 4 1 3 1 2 1 1 TCRgd 3.8 (Yb171)Dd: TCRgd 1 4 1 3 1 2 1 1 TCRgd.377 1 1 1 2 1 3 1 4 (Nd15)Dd: CD3 1 1 1 2 1 3 1 4 (Nd15)Dd: CD3 1 4 CD14+ CD33+ 16.9 1 4 CD14+ CD33+ 8.66 CD33 (Er166)Dd: CD33 1 3 1 2 1 1 (Er166)Dd: CD33 1 3 1 2 1 1 CD14- CD33-82.7 CD14- CD33-91.1 1 1 1 2 1 3 1 4 (Sm154)Dd: CD14 1 1 1 2 1 3 1 4 (Sm154)Dd: CD14

Part 3 Experimental Procedure

CyTOF Sample Info 1. Reagent purity is paramount - MilliQ water only - trace metal pure salts and buffers, if possible 2. All samples - fixed and permeabilized - Thorough fixa&on - Fresh PFA! 3. MilliQ water washes at the end - Proper fixa&on ensure intact cells - Minimizes buffer salt introduc&on into machine 4. Titrate all reagents for your assay condi&ons - Commercial - Every batch of in- house reagents re- verify before use

CyTOF Sample Info Star&ng Cell Count * Remember: only 2-3% cell transmission efficiency - also, processing losses Cells Plated Live intact singlets Titration of cell numbers - Plated vs Live Intact Singlets 2K 28K 15, 5K 1M 76K 175K Live intact singlets 1, 5, R square Live intact Singlets.9895 Yao et al: down to 1K (major only) HIMC: recommend at least 5K 5, 1,, 1,5, Cell #, plated Slope Y-intercept when X=. X-intercept when Y=. Live intact Singlets.1829 ±.188-14297 ± 69 78149

Metal Staining of Cells - DNA Intercalator - Labels any cell containing DNA regardless of whether any labelled an&bodies bind Schaferet al J.Organomet.Chem., 27, 692, 13 139 Ornatsky et al, Anal. Chem., 28, 8, 2539 2547

Chela&ng Polymer Structures X8 linear polymer with ~22 chela&on sites DN3 branched dendrimer, ~16 chela&on sites

An&bodies X8 vs DN3 Comparison

Live- Dead maleimide- DOTA cispla&n

Normaliza&on EQ Four- Element Beads - Polystyrene beads: contain elemental Ce, Eu, Ho, Lu - burn like cells, but are defined composi&on

Normaliza&on Beads - Long Run&me Decrease in Signal Intensity 1:33 AM 6:55 PM

Normaliza&on Affects All Signals Noise amplifica&on! * Global Mean as baseline, rather than Minimum or Maximum - limits noise amplifica&on Normaliza&on CANNOT correct for improper machine cleaning/tuning (undetectable analyte signals). Finck et al, Cytometry A, 213

Signal Decrease Over Very Long Run- Times - Single file: >2 million cells = >3 hr 98% of start 73% of start * Highlights need for moving window normaliza&on Finck et al, Cytometry A, 213

Effects of Normaliza&on - Control sample split in half, run 8.5hr apart; ra&o aker manual ga&ng Freq Parent Median Intensity * Freq Parent fairly robust; only small gains from normaliza&on * Median Intensity more affected by normaliza&on (phosphoflow...)

Part 4 Sample Running

Running Samples 1. Warm up machine ~15-2 min to create and maintain fully hot and stable plasma 2. Tune machine maximize M signal while minimizing M+16 oxide forma&on 3. Finish washing cells final wash in MilliQ water, then resuspension and dilu&on in MilliQ water. - residual buffer salts can affect Current value 4. Resuspend and filter immediately before injec&on - Reduces aggregates (clogs) 5. Appropriate dilu&on minimize doublets - Around 1 cell event/screen refresh; usually ~75K/mL on cell counter

Standard CyTOF Output Appearance 15 - Spike at ~ is legi&mate ( true zero ) - Flow data is usually distributed above and below zero due to comps and auto- fluorescence. # Cells 1 5 CD3-27.8 CD3+ 72.2 * FlowJo se~ngs must be changed for CyTOF data 1 1 1 2 1 3 1 4 CD3(Nd15)Dd: CD3

1 4 Intact cells 76.1 1 4 DNA1(Ir191)Dd: DNA1 1 3 1 2 1 1 DNA1(Ir191)Dd: DNA1 1 3 1 2 1 1 Intact singlets 71.6 1 1 1 2 1 3 1 4 DNA2(Ir193)Dd: DNA2 3 6 9 12 Cell_length: Cell_length CD33(Er166)Dd: CD33 1 4 1 3 1 2 1 1 Monocytes 3.7 Lymphocytes 69.1 DNA1(Ir191)Dd: DNA1 1 4 1 3 1 2 1 1 Live cells 96.1 1 1 1 2 1 3 1 4 CD14(Sm154)Dd: CD14 1 1 1 2 1 3 1 4 Dead(In115)Dd: Dead

CyTOF vs LSRII Representa&ve Examples B Cells CD3+ Cells CD3- Cells Fluorescence <PE-Cy7-A>: CD27 1 5 1 4 1 3 13.6 7.3 <APC-Cy7-A>: CD8 1 5 1 4 1 3 CD8+ 32.1 CD4+ 59.9 <FITC-A>: CD56 1 5 1 4 1 3 1 2 NK cells 19.5 9.51 69.8 1 2 1 3 1 4 1 5 <Am Cyan-A>: IgD 1 2 1 3 1 4 1 5 <PerCP-Cy5-5-A>: CD4 1 2 1 3 1 4 1 5 <Pacific Blue-A>: CD16 Mass CD27(Sm152)Dd: CD27 1 4 1 3 1 2 1 1 14.3 7.64 6.3 72 CD8(Nd144)Dd: CD8 1 4 1 3 1 2 1 1 CD8+ 3.3 CD4+ 61 CD56(Yb174)Dd: CD56 1 4 1 3 1 2 1 1 NK cells 2.1 1 1 1 2 1 3 1 4 IgD(Nd146)Dd: IgD 1 1 1 2 1 3 1 4 CD4(Nd143)Dd: CD4 1 1 1 2 1 3 1 4 CD16(Sm149)Dd: CD16

Flu 21-211 - CyTOF Phenotyping Panel - Collapse 6 tube LSRII panel into 1 tube CyTOF panel 23 markers CD14 CD33 CD3 CD4 CD8 TCRgd CD19 CD2 CD16 CD56 CD45RA CCR7 CD25 CD127 CD27 CD28 CD38 CD85j IgD HLADR CD24 CD94 CD161

Flu 21, Flu 211 Studies - On- going Flu vaccine studies U19 - CyTOF Phenotyping 21, 211 years - Day (pre- vaccina&on) only Study 15, 17, 18 - Day, 1, 4, 7 Study 23-211 - 21-211: >3 unique donors between- donor variability Age Band (y/o) <35 35-65 >65 Total Male 62 22 46 13 Female 84 47 65 196 Total 146 69 111 326

21 Flu Studies Consistency 284 Control - Same Draw, Same Year Replicates

Flu 211, 212 Studies Consistency 885 Control - Generally good year- to- year agreement from same 885 donor draw Naive CD8+ IgD+ CD27- B cells 8 1 Percentage of Parent 6 4 2 Percentage of Parent 8 6 4 2 211 212 Men 35-65 211 212 Men 35-65 Year Year

Flu 211, 212 Studies Consistency 885 Control - Some&mes greater variability in less- frequent popula&ons CD4+ Treg 1 8 Percentage of Parent 6 4 2 211 212 Men 35-65 Year

Flu 21, Flu 211 Studies Donor Variability 8 **** *** B cells total **** **** Percentage of Parent 6 4 2 Mann- Whitney two- tailed * <.5 ** <.1 *** <.1 **** <.1 Men <35 Men 35-65 Men >65 Women <35 Gender and Age Band Women 35-65 Women >65

Flu 21, Flu 211 Studies Donor Variability Mann- Whitney two- tailed * <.5 ** <.1 *** <.1 **** <.1 Percentage of Parent 1 8 6 4 2 **** CD4+ total **** *** Men <35 Men 35-65 Men >65 Women <35 Gender and Age Band Women 35-65 Women >65 Percentage of Parent 1 8 6 4 2 **** *** ** CD4+ Naive **** **** * Percentage of Parent 1 8 6 4 2 CD4+ Effector Memory *** * * Men <35 Men 35-65 Men >65 Women <35 Gender and Age Band Women 35-65 Women >65 Men <35 Men 35-65 Men >65 Women <35 Gender and Age Band Women 35-65 Women >65

Flu 21, Flu 211 Studies Donor Variability Mann- Whitney two- tailed * <.5 ** <.1 *** <.1 **** <.1 Percentage of Parent 8 6 4 2 * * CD8+ total **** *** * Men <35 Men 35-65 Men >65 Women <35 Gender and Age Band Women 35-65 Women >65 Percentage of Parent 1 8 6 4 2 **** **** **** CD8+ Naive **** **** **** Percentage of Parent 1 8 6 4 2 CD8+ Effector Memory **** **** * **** *** **** -2 Men <35 Men 35-65 Men >65 Women <35 Gender and Age Band Women 35-65 Women >65 Men <35 Men 35-65 Men >65 Women <35 Gender and Age Band Women 35-65 Women >65

Study 23-211 (Sm152)Dd: CD27 1 4 1 3 1 2 1 1 CD27+ CD38+.465 Day Day 1 (Sm152)Dd: CD27 1 4 1 3 1 2 1 1 CD27+ CD38+.338 1 1 1 2 1 3 1 4 (Eu151)Dd: CD38 1 1 1 2 1 3 1 4 (Eu151)Dd: CD38 (Sm152)Dd: CD27 1 4 1 3 1 2 1 1 Day 4 Day 7 CD27+ CD38+.566 (Sm152)Dd: CD27 1 4 1 3 1 2 1 1 CD27+ CD38+ 2.26 1 1 1 2 1 3 1 4 (Eu151)Dd: CD38 1 1 1 2 1 3 1 4 (Eu151)Dd: CD38

Conclusions 1. Proper tuning of the CyTOF ensures minimal sample oxida&on. 2. Metal purity (both elemental and isotopic) is highly important. 3. The choice of metal label is dependent upon marker abundance, modality, and resolu&on needed (fold- change). 4. All samples must be stained with metals to be detected by the CyTOF. Proper fixa&on is important, as are MilliQ water washes. 5. Head- to- head comparisons with LSRII assays are consistent. 6. The Flu studies are an example of how a CyTOF panel can be used to monitor the surface phenotype for hundreds of donors to detect varia&ons between gender, age- band, and &me- point.

Acknowledgements - HIMC staff - Henrik Mei, Meena Malipotlalla, Holden Maecker - External CyTOF: - Nolan lab: Sean Bendall, Erin Simonds, Eli Zunder, Bernd Bodenmiller - Davis lab: Evan Newell, Bill O'Gorman, Peber Brodin - Fluidigm/DVS Sciences - U19 NIH Grants and HIMC Service Center fees hbp://himc.stanford.edu